Hennessy BT - Search Results

1

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.

Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB. Hennessy BT, et al. Clin Proteomics. 2010 Dec;6(4):129-51. doi: 10.1007/s12014-010-9055-y. Clin Proteomics. 2010. PMID: 21691416 Free PMC article.

2

Exploiting the PI3K/AKT pathway for cancer drug discovery.

Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Hennessy BT, et al. Nat Rev Drug Discov. 2005 Dec;4(12):988-1004. doi: 10.1038/nrd1902. Nat Rev Drug Discov. 2005. PMID: 16341064 Review.

3

Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics.

Hennessy BT, Gonzalez-Angulo AM, Hortobagyi GN. Hennessy BT, et al. Nat Clin Pract Oncol. 2005 Dec;2(12):598-9. doi: 10.1038/ncponc0375. Nat Clin Pract Oncol. 2005. PMID: 16341096 No abstract available.

4

Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.

Hennessy BT, Mills GB. Hennessy BT, et al. Int J Biochem Cell Biol. 2006;38(9):1450-6. doi: 10.1016/j.biocel.2006.01.009. Epub 2006 Feb 21. Int J Biochem Cell Biol. 2006. PMID: 16682246 Review.

5

Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Stemke-Hale K, Hennessy B, Mills GB, Mitra R. Stemke-Hale K, et al. Curr Oncol Rep. 2006 Nov;8(6):484-91. doi: 10.1007/s11912-006-0078-5. Curr Oncol Rep. 2006. PMID: 17040626 Review.

6

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB, Kornblau SM. Tibes R, et al. Mol Cancer Ther. 2006 Oct;5(10):2512-21. doi: 10.1158/1535-7163.MCT-06-0334. Mol Cancer Ther. 2006. PMID: 17041095

7

Point mutations of protein kinases and individualised cancer therapy.

Davies M, Hennessy B, Mills GB. Davies M, et al. Expert Opin Pharmacother. 2006 Nov;7(16):2243-61. doi: 10.1517/14656566.7.16.2243. Expert Opin Pharmacother. 2006. PMID: 17059381 Review.

8

Non-parametric quantification of protein lysate arrays.

Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB. Hu J, et al. Among authors: hennessy bt. Bioinformatics. 2007 Aug 1;23(15):1986-94. doi: 10.1093/bioinformatics/btm283. Epub 2007 Jun 28. Bioinformatics. 2007. PMID: 17599930

9

Trends for inflammatory breast cancer: is survival improving?

Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobágyi GN. Gonzalez-Angulo AM, et al. Among authors: hennessy bt. Oncologist. 2007 Aug;12(8):904-12. doi: 10.1634/theoncologist.12-8-904. Oncologist. 2007. PMID: 17766649 Free article.

10

Pharmacodynamic markers of perifosine efficacy.

Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Hennessy BT, et al. Clin Cancer Res. 2007 Dec 15;13(24):7421-31. doi: 10.1158/1078-0432.CCR-07-0760. Clin Cancer Res. 2007. PMID: 18094426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page